StockData
OPKO Health, Inc. logo

OPKO Health, Inc. (OPK) stock

OPKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/305% above fair value
$1.57−0.04 (-2.48%)

Close on Nov 20, 2026Market cap $1.17BP/E –Yield –

OPKO Health free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

OPKO Health's free cash flow for the twelve months ending Jun 30, 2026 was -$134.02M. For fiscal 2025 it was -$190.82M. The highest annual figure on record is $153.18M in fiscal 2015.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$190.82M–
FY2024Dec 31, 2024-$208.50M–
FY2023Dec 31, 2023-$44.47M–
FY2022Dec 31, 2022-$119.77M-2037.7%
FY2021Dec 31, 2021$6.18M+6.7%
FY2020Dec 31, 2020$5.79M–
FY2019Dec 31, 2019-$185.26M–
FY2018Dec 31, 2018-$137.00M–
FY2017Dec 31, 2017-$138.60M-1126.8%
FY2016Dec 31, 2016$13.50M-91.2%
FY2015Dec 31, 2015$153.18M–
FY2014Dec 31, 2014-$95.11M–
FY2013Dec 31, 2013-$59.62M–
FY2012Dec 31, 2012-$26.89M–
FY2011Dec 31, 2011-$20.45M–
FY2010Dec 31, 2010-$19.49M–
FY2009Dec 31, 2009-$23.58M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$46.50M–
Q1 FY2026Mar 31, 2026-$21.14M–
Q4 FY2025Dec 31, 2025-$28.59M–
Q3 FY2025Sep 30, 2025-$37.78M–
Q2 FY2025Jun 30, 2025-$86.70M–
Q1 FY2025Mar 31, 2025-$37.75M–
Q4 FY2024Dec 31, 2024-$49.82M–
Q3 FY2024Sep 30, 2024-$85.02M-394.1%
Q2 FY2024Jun 30, 2024-$33.65M–
Q1 FY2024Mar 31, 2024-$40.01M–
Q4 FY2023Dec 31, 2023-$41.32M–
Q3 FY2023Sep 30, 2023$28.91M–
Q2 FY2023Jun 30, 2023-$6.38M–
Q1 FY2023Mar 31, 2023-$25.68M–
Q4 FY2022Dec 31, 2022-$37.96M–
Q3 FY2022Sep 30, 2022-$39.85M-252.3%
Q2 FY2022Jun 30, 2022-$16.86M–
Q1 FY2022Mar 31, 2022-$25.11M-249.5%
Q4 FY2021Dec 31, 2021-$12.37M-145.1%
Q3 FY2021Sep 30, 2021$26.16M-50.9%
Q2 FY2021Jun 30, 2021-$24.40M–
Q1 FY2021Mar 31, 2021$16.79M–
Q4 FY2020Dec 31, 2020$27.46M–
Q3 FY2020Sep 30, 2020$53.28M–
Q2 FY2020Jun 30, 2020-$25.95M–
Q1 FY2020Mar 31, 2020-$49.00M–
Q4 FY2019Dec 31, 2019-$49.91M–
Q3 FY2019Sep 30, 2019-$26.30M–
Q2 FY2019Jun 30, 2019-$57.13M–
Q1 FY2019Mar 31, 2019-$51.92M–
Q4 FY2018Dec 31, 2018-$37.69M–
Q3 FY2018Sep 30, 2018-$33.91M–
Q2 FY2018Jun 30, 2018-$23.90M–
Q1 FY2018Mar 31, 2018-$41.49M–
Q4 FY2017Dec 31, 2017-$12.35M-142.9%
Q3 FY2017Sep 30, 2017-$52.86M–
Q2 FY2017Jun 30, 2017-$29.93M–
Q1 FY2017Mar 31, 2017-$43.46M–
Q4 FY2016Dec 31, 2016$28.77M–
Q3 FY2016Sep 30, 2016-$36.05M–

More OPKO Health figures

See a number that looks wrong?